Effect of endocrine treatment on voiding and prostate size in men with prostate cancer: A long-term prospective study-Reference-Cited by-同舟云学术

Effect of endocrine treatment on voiding and prostate size in men with prostate cancer: A long-term prospective study

Published:2011-12-12 Issue:1 Volume:46 Page:37-43
ISSN:0036-5599
Container-title:Scandinavian Journal of Urology and Nephrology
language:en
Short-container-title:Scandinavian Journal of Urology and Nephrology

Author:

Klarskov Louise L.¹,Klarskov Peter²,Mommsen Søren³,Svolgaard Niels⁴

Affiliation:

1. Clinical Research Center, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark

2. Section of Urology, Department of Surgery, Glostrup Hospital, Glostrup, Denmark, and Department of Urology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark

3. Section of Urology, Department of Surgery, Randers Central Hospital, Randers, Denmark, and Section of Urology, Department of Surgery, Middelfart Hospital, Middelfart, Denmark

4. Department of Urology, Odense University Hospital, Odense, Denmark

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.3109/00365599.2011.637953

Reference21 articles.

1. Alpha-Blocker Therapy Can Be Withdrawn in the Majority of Men Following Initial Combination Therapy with the Dual 5α-Reductase Inhibitor Dutasteride

2. Comparative efficacy of two α1-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement

3. COMBINATION OF AN α1-BLOCKER, ALFUZOSIN AND A PDE5 INHIBITOR, SILDENAFIL CITRATE, IS SUPERIOR TO MONOTHERAPY IN TREATING LOWER URINARY TRACT SYMPTOMS AND SEXUAL DYSFUNCTION

4. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

5. Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescription rates for drugs used in treatment of benign prostatic hyperplasia and erectile dysfunction before and after prostate cancer diagnosis;Acta Oncologica;2022-06-06

2. Effects of low‑dose bufalin combined with hydroxycamptothecin on human castration‑resistant prostate cancer xenografts in nude mice;Experimental and Therapeutic Medicine;2021-07-15

3. LEUPROLIDE ACETATE VERSUS GOSERELIN ACETATE: A RESEARCH STUDY TO ASSESS THE HORMONAL THERAPY EFFECTS ON RELIEF OF LOWER UTI SYMPTOMS, VOLUME REDUCTION AND PROSTATE CANCER;INDO AM J PHARM SCI;2019

4. Can androgen-deprivation therapy obviate the need of channel transurethral resection of the prostate in advanced prostate cancer with urinary retention? A prospective study;Arab Journal of Urology;2017-12

5. Clinical evaluation of tamsulosin in the relief of lower urinary tract symptoms in advanced prostate cancer patients;International Urology and Nephrology;2017-04-13